Endometrial Mucinous Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Endometrial Mucinous Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma [Phase 2]
This Phase 2 trial investigates nivolumab with or without ipilimumab in mismatch repair–deficient (dMMR) recurrent endometrial cancer and is…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
MD Anderson Cancer Center is conducting a study to determine if liquid biopsies and tumor molecular profiling can predict recurrence in vari…
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer [Phase 1]
A Phase 1 trial evaluating the combination of dasatinib, paclitaxel, and carboplatin in patients with Stage III-IV or recurrent endometrial …
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial of brivanib alaninate in patients with recurrent or persistent endometrial cancer has completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2016-02-05Clinical Trial Update: Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer [Phase 2]
A Phase 2 clinical trial evaluating dalantercept for recurrent or persistent endometrial cancer has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.